Chemoinformaics analysis of ethyl 9Z-tetradecenoate
| Molecular Weight | 254.414 | nRot | 12 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 2 |
| Exact Molecular Weight | 254.225 | nRing | 0 |
| Solubility: LogS | -4.046 | nHRing | 0 |
| Solubility: LogP | 4.933 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.3278 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.277 |
| Synth | 2.05 |
| Natural Product Likeliness | 0.795 |
| NR-PPAR-gamma | 0.142 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.032 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.702 |
| MDCK | 0.0000315 |
| BBB | 0.564 |
| PPB | 0.972074 |
| VDSS | 1.847 |
| FU | 0.0176078 |
| CYP1A2-inh | 0.895 |
| CYP1A2-sub | 0.348 |
| CYP2c19-inh | 0.657 |
| CYP2c19-sub | 0.12 |
| CYP2c9-inh | 0.564 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.31 |
| CYP2d6-sub | 0.376 |
| CYP3a4-inh | 0.608 |
| CYP3a4-sub | 0.13 |
| CL | 5.169 |
| T12 | 0.872 |
| hERG | 0.271 |
| Ames | 0.029 |
| ROA | 0.061 |
| SkinSen | 0.951 |
| Carcinogencity | 0.144 |
| EI | 0.964 |
| Respiratory | 0.706 |
| NR-Aromatase | 0.065 |
| Antiviral | Yes |
| Prediction | 0.711475 |